4//SEC Filing
Kayyem Jon Faiz 4
Accession 0002007919-24-000006
CIK 0002007919other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:27 PM ET
Size
13.4 KB
Accession
0002007919-24-000006
Insider Transaction Report
Form 4
Kayyem Jon Faiz
Director
Transactions
- Purchase
Common Stock
2024-06-04$17.44/sh+65,337$1,139,477→ 1,069,135 total(indirect: By Trust) - Purchase
Common Stock
2024-05-31$16.14/sh+70,193$1,132,915→ 876,268 total(indirect: By Trust) - Purchase
Common Stock
2024-06-03$17.90/sh+80,738$1,445,210→ 1,003,798 total(indirect: By Trust) - Purchase
Common Stock
2024-06-04$18.24/sh+23,726$432,762→ 1,092,861 total(indirect: By Trust) - Purchase
Common Stock
2024-06-03$16.61/sh+46,792$777,215→ 923,060 total(indirect: By Trust)
Footnotes (5)
- [F1]The shares were purchased in multiple transactions at prices ranging from $15.75 to $16.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The shares were purchased in multiple transactions at prices ranging from $16.25 to $16.75, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]The shares were purchased in multiple transactions at prices ranging from $17.40 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F4]The shares were purchased in multiple transactions at prices ranging from $17.01 to $18.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F5]The shares were purchased in multiple transactions at prices ranging from $18.01 to $18.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001366268
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:27 PM ET
- Size
- 13.4 KB